These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 8757046)
1. Idebenone improves cerebral mitochondrial oxidative metabolism in a patient with MELAS. Ikejiri Y; Mori E; Ishii K; Nishimoto K; Yasuda M; Sasaki M Neurology; 1996 Aug; 47(2):583-5. PubMed ID: 8757046 [TBL] [Abstract][Full Text] [Related]
2. Long-term treatment with idebenone and riboflavin in a patient with MELAS. Napolitano A; Salvetti S; Vista M; Lombardi V; Siciliano G; Giraldi C Neurol Sci; 2000; 21(5 Suppl):S981-2. PubMed ID: 11382201 [TBL] [Abstract][Full Text] [Related]
3. Effect of long-term oral treatment with L-arginine and idebenone on the prevention of stroke-like episodes in an adult MELAS patient. Lekoubou A; Kouamé-Assouan AE; Cho TH; Luauté J; Nighoghossian N; Derex L Rev Neurol (Paris); 2011 Nov; 167(11):852-5. PubMed ID: 21514942 [TBL] [Abstract][Full Text] [Related]
4. [A case of mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes (MELAS)--treatment with coenzyme Q10 and idebenone]. Ihara Y; Namba R; Kuroda S Rinsho Shinkeigaku; 1988 Jan; 28(1):62-6. PubMed ID: 3383514 [No Abstract] [Full Text] [Related]
5. Secondary coenzyme Q10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts. Cotán D; Cordero MD; Garrido-Maraver J; Oropesa-Ávila M; Rodríguez-Hernández A; Gómez Izquierdo L; De la Mata M; De Miguel M; Lorite JB; Infante ER; Jackson S; Navas P; Sánchez-Alcázar JA FASEB J; 2011 Aug; 25(8):2669-87. PubMed ID: 21551238 [TBL] [Abstract][Full Text] [Related]
6. Cerebral metabolism of oxygen and glucose in a patient with MELAS syndrome. Sano M; Ishii K; Momose Y; Uchigata M; Senda M Acta Neurol Scand; 1995 Dec; 92(6):497-502. PubMed ID: 8750117 [TBL] [Abstract][Full Text] [Related]
7. Coenzyme Q10 improves psychiatric symptoms in adult-onset mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: a case report. Shinkai T; Nakashima M; Ohmori O; Terao T; Nakamura J; Hiramatsu N; Hashiguchi H; Tsuji S Aust N Z J Psychiatry; 2000 Dec; 34(6):1034-5. PubMed ID: 11127618 [No Abstract] [Full Text] [Related]
8. MR OEF imaging in MELAS. Xie S Methods Enzymol; 2014; 547():433-44. PubMed ID: 25416369 [TBL] [Abstract][Full Text] [Related]
9. Effect of coenzyme Q10 in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): evaluation by noninvasive tissue oximetry. Abe K; Matsuo Y; Kadekawa J; Inoue S; Yanagihara T J Neurol Sci; 1999 Jan; 162(1):65-8. PubMed ID: 10064171 [TBL] [Abstract][Full Text] [Related]
10. Border between natural product and drug: comparison of the related benzoquinones idebenone and coenzyme Q10. Gueven N; Woolley K; Smith J Redox Biol; 2015; 4():289-95. PubMed ID: 25625583 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial encephalomyopathy (MELAS): pathological study and successful therapy with coenzyme Q10 and idebenone. Ihara Y; Namba R; Kuroda S; Sato T; Shirabe T J Neurol Sci; 1989 May; 90(3):263-71. PubMed ID: 2738608 [TBL] [Abstract][Full Text] [Related]
12. Successful treatment with succinate in a patient with MELAS. Oguro H; Iijima K; Takahashi K; Nagai A; Bokura H; Yamaguchi S; Kobayashi S Intern Med; 2004 May; 43(5):427-31. PubMed ID: 15206559 [TBL] [Abstract][Full Text] [Related]
13. MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options. El-Hattab AW; Adesina AM; Jones J; Scaglia F Mol Genet Metab; 2015; 116(1-2):4-12. PubMed ID: 26095523 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of lipid peroxidation by idebenone in brain mitochondria in the presence of succinate. Suno M; Nagaoka A Arch Gerontol Geriatr; 1989 May; 8(3):291-7. PubMed ID: 2764644 [TBL] [Abstract][Full Text] [Related]
15. MR evaluation of cerebral oxygen metabolism and blood flow in stroke-like episodes of MELAS. Wang Z; Xiao J; Xie S; Zhao D; Liu X; Zhang J; Yuan Y; Huang Y J Neurol Sci; 2012 Dec; 323(1-2):173-7. PubMed ID: 23062409 [TBL] [Abstract][Full Text] [Related]
16. Mitochondria: role of citrulline and arginine supplementation in MELAS syndrome. El-Hattab AW; Emrick LT; Chanprasert S; Craigen WJ; Scaglia F Int J Biochem Cell Biol; 2014 Mar; 48():85-91. PubMed ID: 24412347 [TBL] [Abstract][Full Text] [Related]
17. Idebenone in patients with Friedreich ataxia. Schöls L; Vorgerd M; Schillings M; Skipka G; Zange J Neurosci Lett; 2001 Jun; 306(3):169-72. PubMed ID: 11406322 [TBL] [Abstract][Full Text] [Related]
18. The addition of ketone bodies alleviates mitochondrial dysfunction by restoring complex I assembly in a MELAS cellular model. Frey S; Geffroy G; Desquiret-Dumas V; Gueguen N; Bris C; Belal S; Amati-Bonneau P; Chevrollier A; Barth M; Henrion D; Lenaers G; Bonneau D; Reynier P; Procaccio V Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):284-291. PubMed ID: 27815040 [TBL] [Abstract][Full Text] [Related]
19. Biochemical study of idebenone effect on mitochondrial metabolism of yeast. Chapela SP; Burgos HI; Salazar AI; Nievas I; Kriguer N; Stella CA Cell Biol Int; 2008 Jan; 32(1):146-50. PubMed ID: 17900937 [TBL] [Abstract][Full Text] [Related]
20. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Matthews RT; Yang L; Browne S; Baik M; Beal MF Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8892-7. PubMed ID: 9671775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]